Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P41279
UPID:
M3K8_HUMAN
Alternative names:
Cancer Osaka thyroid oncogene; Proto-oncogene c-Cot; Serine/threonine-protein kinase cot; Tumor progression locus 2
Alternative UPACC:
P41279; A8K2Q5; D3DRX1; Q14275; Q5T855; Q9HC81
Background:
Mitogen-activated protein kinase kinase kinase 8, also known as Cancer Osaka thyroid oncogene, Proto-oncogene c-Cot, and Serine/threonine-protein kinase cot, plays a pivotal role in immune responses. It is essential for the activation of the MAPK/ERK pathway in macrophages, facilitating the production of TNF-alpha, a key pro-inflammatory cytokine. Additionally, it regulates T-helper cell differentiation, IFNG expression in T-cells, and mediates host resistance to bacterial infection by modulating type I interferon production. Its involvement extends to activating the MAPK/ERK pathway in response to IL1 and TNF in various cells, including adipocytes, and it has a role in immunoglobulin production and cell cycle regulation.
Therapeutic significance:
Understanding the role of Mitogen-activated protein kinase kinase kinase 8 could open doors to potential therapeutic strategies.